Clinical Trial: FDA-Approved CBD Formulation Reduces Post-Operative Opioid Consumption Following Knee Replacement Surgery
November 19, 2026
November 19, 2026
WASHINGTON, Nov. 19 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Clinical Trial: FDA-Approved CBD Formulation Reduces Post-Operative Opioid Consumption Following Knee Replacement Surgery
*
New York, NY: Knee replacement patients administered 400 mg of the FDA-approved plant-derived CBD prescription medicine Epidiolex experience less postoperative pain and require . . .
* * *
Clinical Trial: FDA-Approved CBD Formulation Reduces Post-Operative Opioid Consumption Following Knee Replacement Surgery
*
New York, NY: Knee replacement patients administered 400 mg of the FDA-approved plant-derived CBD prescription medicine Epidiolex experience less postoperative pain and require . . .
